CDTX vs HCA · rev $1.3M vs P/E 17, rev $75.60B
Cidara Therapeutics Inc (CDTX) versus HCA Holdings Inc (HCA) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
CDTX currently screens at market cap $6.96B. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Not investment advice. Open the CDTX and HCA stock pages for the full models.
Not investment advice.